SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): October 22, 2002
HAEMONETICS CORPORATION
(Exact Name of Registrant as Specified in its Charter)
Massachusetts 1-10730 04-2882273
------------- ------- ----------
(State or other jurisdiction of (Commission File (IRS Employer
incorporation or organization) Number) Identification Number)
400 Wood Road
Braintree, MA 02184
------------- -----
(Address of principal executive (Zip Code)
offices)
Registrant's telephone number, including area code (781) 848-7100
Item 5. Other Events
----------------------
On October 22, 2002, Sir Stuart Burgess, Chairman of Haemonetics
Corporation (the "Company"), announced his intention to retire in March
2003 at the end of the Company's fiscal year. The Company simultaneously
announced that Ronald A. Matricaria, former CEO and Chairman of St. Jude
Medical Inc., has joined the Board today and will succeed Sir Stuart as
Chairman on April 1, 2003.
Item 7. Financial Statements and Exhibits.
--------------------------------------------
(c) Exhibits.
99.1 Press Release of the Company dated October 22, 2002
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
HAEMONETICS CORPORATION
Date: October 22, 2002 By: s/Ronald J. Ryan
---------------- ---------------------------------
Ronald J. Ryan, Senior Vice
President and Chief Financial
Officer
3